Shlomo Noy
CIK: 0002033211
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SLXN
Silexion Therapeutics Corp
Director
Discretionary Trading P&L
Holdings
About Noy Shlomo
Noy Shlomo (SEC CIK 0002033211) files insider reports with the SEC as Director of Silexion Therapeutics Corp (SLXN).
Signal8 holds 2 ownership filings by Noy Shlomo, all Form 4s, filed between Dec 31, 2025 and Feb 25, 2026. Those filings report 2 transactions, from Feb 9, 2025 to Feb 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Noy Shlomo's filings is in TEL AVIV, L3.
Recent filings by Noy Shlomo
Other insiders filing for Silexion Therapeutics Corp (SLXN)
- Shirvan Mitchell, CSO and CDO
- Horenshtein Hadar Mirit, CFO and Secretary
- Hadar Ilan, Chairman and CEO
- Alon Ruth, Director
- Abramov Dror Yosef, Director
- Peled Amnon, Director